Drugs · Brain health technique

Rapamycin / Everolimus

Evidence grade: Experimental

Illustration for Rapamycin / Everolimus

Drugs that inhibit the mTOR (mechanistic target of rapamycin) pathway, sirolimus (Rapamune®) and everolimus (Afinitor®), used in oncology and transplant medicine, now studied for anti-aging and neuroprotective effects.

Practice
Drugs
Principle
Treatment
Tactic
Emerging Longevity / Neuroregenerative Agents
Health domains
neurocognitive
Evidence grade
Experimental
Strength of evidence
Low
Cost
High
Effort
Low
Time commitment
Low

How to practice Rapamycin / Everolimus

Should only be used under clinical supervision or research protocols. Off-label “longevity” dosing typically 2–6 mg weekly is being studied but not standardized. Regular monitoring of glucose, lipids, and immune markers is essential. Avoid self-administration; consider awaiting results of ongoing human neuroprotection and aging trials. May have disproportionate benefit to APOE4 carriers.

The evidence behind Rapamycin / Everolimus

These drugs block mTOR (a protein that controls cell growth). That action boosts autophagy and cuts protein clumping and inflammation. Low doses extend lifespan in animals. Human data on anti-aging use come only from small trials on aging and immune function, and the long-term safety of that use is unproven. Risks include insulin resistance, mouth ulcers, and a weaker immune system.

Impact on brain health

Autophagy, less protein clumping, and less inflammation all help prevent neurodegeneration. Low doses also improve memory and thinking in animal studies, but cognitive benefits in people are unproven.

Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science

Pair this with other habits from the same practice.

  • Evidence grade: Context Dependent

    Anti-Amyloid Monoclonal Antibodies

    FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

    Medium effort

  • Evidence grade: Context Dependent

    Antihypertensives

    Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

    Low effort · High cost

  • Evidence grade: Context Dependent

    GLP-1 Receptor Agonists

    A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.

See all 20 drugs techniques →

Take control of your brain health

BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.

How BetterBrain worksSee pricing